SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: Doc Hollywood
Search This Board: 
Last Post: 3/24/2017 3:25:54 PM - Followers: 48 - Board type: Free - Posts Today: 0

 


 

Company

 

InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

 

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm.
     
     

CGuard™

 

cgaurd  

v

Dual Layer Design

Open cell stent platform wrapped in MicroNet mesh

MicroNetTM v

For continuous embolic prevention

v

SmartFitTM Technology

Eliminates need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

 

Product Details:

  • CGuard material: Nitinol

MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system

     

MGuard™

Expand_s003.small  

vMicroNetTM Technology

For continuous embolic protection

Proven Safety and Efficacyv

Used in thousands of patients

v

Strut Thickness

100 microns


Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316
 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

 

MGuard-Prime-e1407751799122  

v

MicroNetTM Technology

For continuous embolic protection

Cobalt Chromiumv

Highly biocompatible

v

Strut Thickness

80 microns


Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/

 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

 

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at [email protected] or 1-888-776-6804.

 

map

Executives

 

board_jb-02
James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

exe_shore
Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

image002_web
Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

20161102_191058_web
Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

20161106_103740_web
Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…



Website
http://www.inspiremd.com/en/




     
  •  
     
     

  •  


 


 

 

 

      
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NSPR
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#688   Good point. Thanks for clarifying. Doc Hollywood 03/24/17 03:25:54 PM
#687   Hey doc I'm long on this stock not moneyman419 03/24/17 03:23:28 PM
#686   Considering this is a company that sells stents Doc Hollywood 03/24/17 02:53:09 PM
#685   Still having trouble breaking through .93. Don't know Doc Hollywood 03/24/17 12:34:15 PM
#684   Good entry point imo. Lot of buys at Doc Hollywood 03/24/17 12:05:44 PM
#683   in @ .93. risk/reward looks favorable. sootman 03/24/17 11:59:56 AM
#682   Edge to the sellers at the open today. Doc Hollywood 03/24/17 09:47:32 AM
#681   run up then fallback..thats history here..been very volitale..but bill_y 03/24/17 08:40:52 AM
#680   ultimately about sales and revenue..the russian agreement looks bill_y 03/24/17 08:24:50 AM
#679   Always the same question on every low float Doc Hollywood 03/23/17 11:25:33 AM
#678   NSPR trades over 2 mil shares at 1.01-1.05 Johnstown 03/23/17 11:14:28 AM
#677   No reason I can see for this to Doc Hollywood 03/23/17 10:44:40 AM
#676   BOSTON, MA / ACCESSWIRE / March 23, 2017 Doc Hollywood 03/23/17 09:19:44 AM
#675   Bought in at 99 cents this morning. The Doc Hollywood 03/23/17 09:07:34 AM
#674   I'd agree that it looks like shorts have Sasquatch81 03/23/17 09:02:01 AM
#673   could not find short interest numbers either..may not bill_y 03/23/17 08:15:38 AM
#672   That's all I've found as well. It took Sasquatch81 03/23/17 08:05:06 AM
#671   anyone know current market cap...all i can find bill_y 03/23/17 07:56:19 AM
#670   I'd say the chances are good based on Sasquatch81 03/23/17 06:50:26 AM
#669   Is this thing going to run back up today!? mcpgroup 03/23/17 05:28:29 AM
#668   Nice volume and price spike this morning! Sasquatch81 03/17/17 09:45:28 AM
#667   Come on really, this thing needs to go speedstar 03/15/17 06:59:33 PM
#666   NOPE!! TOOK MY $700+LOSS! Wish i had woke-up makingbiigdough 03/14/17 02:19:03 PM
#665   i got in at 124, taking a clobbering, NYCJR 03/14/17 02:07:30 PM
#664   TERRIBLE TRADING I'M OUT!!! Look for the LAWSUIT makingbiigdough 03/14/17 01:56:08 PM
#663   Just getting up! WHAT THE HECK IS GOING makingbiigdough 03/14/17 01:27:09 PM
#662   I'm going to pick up a few at Sasquatch81 03/14/17 09:53:06 AM
#661   Looks like the NSPR reversal is going to makingbiigdough 03/13/17 12:18:35 PM
#660   Waaay OVERSOLD AT THESE LEVELS!! In at $1.18!! MBD makingbiigdough 03/10/17 10:51:01 AM
#659   Thanks a lot for that information. Very helpful JBZ 02/08/17 11:18:29 AM
#658   What I think is happening is people remember stocktrademan 02/08/17 09:49:36 AM
#657   What's wrong here? Lvl 2 looks stacked on JBZ 02/08/17 09:41:50 AM
#656   Haven't seen any news lately but keep an stocktrademan 02/07/17 12:31:05 PM
#655   Anything going on here?? speedstar 02/07/17 12:14:27 PM
#654   NSPR bullish 2.736 stocktrademan 12/06/16 10:53:45 AM
#653   4.40 will be plenty of a gain for Moto260 11/23/16 08:52:22 AM
#652   $4.4 very key point. If it rejects and NASDAQjack 11/23/16 08:24:06 AM
#651   Got us a Gapper =D Congrats Moto260 11/22/16 04:45:13 PM
#650   Crickets in this place Where is everyone. Moto260 11/22/16 03:55:53 PM
#649   NSPR bullish 2.51 stocktrademan 11/20/16 10:21:53 AM
#648   Trump -ok beambe 11/09/16 03:54:36 PM
#647   Short :-) beambe 11/07/16 03:52:51 PM
#646   or 1 Cent-beambe BINGO beambe 11/07/16 03:52:11 PM
#645   GOOO 0,073 :-) beambe 11/07/16 03:35:39 PM
#644   GOOO 1,589 beambe 11/03/16 03:58:37 PM
#643   I like this Share beambe 11/03/16 03:49:07 PM
#642   Close RED $$$ beambe 11/03/16 02:58:31 PM
#641   Short :-) beambe 11/03/16 01:37:25 PM
#635   Magadino group. > Brooklyn crudeoil24 11/01/16 10:58:19 PM
#634   * * $NSPR Video Chart 11-01-16 * * ClayTrader 11/01/16 05:11:32 PM
PostSubject